No dispatches yet.

Eterna SCS

by Abbott LaboratoriesUS

Smallest rechargeable SCS system for chronic pain. Uses low-dose BurstDR stimulation.

DeployStage 4 of 5

FDA approved Dec 2022. Smallest rechargeable SCS. Five recharges/year. Approved for chronic pain.

Updated Dec 2022Checked 10 Oct0 updates this week

Milestones

No announced next step
  1. Eterna development2018Complete.
  2. FDA approvalDec 2022Complete.
  3. Market launchQ1 2023Complete.
Primer